[Modification of blood coagulation through Arwin].
D000818:Animals; D001777:Blood Coagulation / Q000187:drug effects*; D001779:Blood Coagulation Factors; D001809:Blood Viscosity / Q000187:drug effects; D004285:Dogs; D057487:Enzyme Therapy; D004798:Enzymes / Q000494:pharmacology; D005340:Fibrinogen; D005342:Fibrinolysis / Q000187:drug effects; D006460:Hemolysin Proteins / Q000494:pharmacology* / Q000627:therapeutic use*; D006801:Humans; D007275:Injections, Intravenous; D008296:Malaysia; D012911:Snakes; D013045:Species Specificity; D013916:Thrombelastography; D013923:Thromboembolism / Q000188:drug therapy; D014688:Venoms
D001779:Blood Coagulation Factors; D004798:Enzymes; D006460:Hemolysin Proteins; D014688:Venoms; D005340:Fibrinogen
Die Beeinflussung der Blutgerinnung durch Arwin